Virtual pulmonary rehabilitation

1 paper4 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Humans1

Outcomes

Hypertension

downin humans1

1 study

Virtual pulmonary rehabilitation decreases hypertension in humans.
“The program was also associated with decreased smoking rates and a lower prevalence of hypertension post-intervention.”
Humansin adults with COPDn = 2,444
Addressing Gaps in Pulmonary Rehabilitation: Evaluation of a Virtual Pulmonary Rehabilitation Platform
JMIR formative research11 Aug 2026

Latest

1 in 12 months

JMIR Formative Research14 Aug

Addressing Gaps in Pulmonary Rehabilitation: Evaluation of a Virtual Pulmonary Rehabilitation Platform

Cohort study of 2,444 peopleChronic obstructive pulmonary disease

Paper

Virtual pulmonary rehabilitation

Outcomes

Latest

Addressing Gaps in Pulmonary Rehabilitation: Evaluation of a Virtual Pulmonary Rehabilitation Platform

Related